FdaApplication
NDA 020699
Identifiers
- fda_app_no: NDA020699
Properties
| Property | Value |
|---|---|
| applicant_name | UPJOHN US 2 LLC |
| application_type | NDA |
| approval_date | 1997-10-20 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE, EXTENDED RELEASE;ORAL |
| EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | EQ 150MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
4 products